Viscidi et al., 2006 - Google Patents
Serological cross reactivity between polyomavirus capsidsViscidi et al., 2006
View PDF- Document ID
- 7944441713996285355
- Author
- Viscidi R
- Clayman B
- Publication year
- Publication venue
- Polyomaviruses and human diseases
External Links
Snippet
Multiple methods have been used to measure antibodies to polyomavirus virions. In order to have a common method for all polyomaviruses, we developed enzyme immunoassays (EIAs) using virus-like-particles (VLPs) produced in the baculovirus expression system. We …
- 241001505332 Polyomavirus sp. 0 title abstract description 49
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
- C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Viscidi et al. | Serological cross reactivity between polyomavirus capsids | |
Viscidi et al. | Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays | |
Carter et al. | Lack of serologic evidence for prevalent simian virus 40 infection in humans | |
Chen et al. | Inter-and intragenus structural variations in caliciviruses and their functional implications | |
DeCaprio et al. | A cornucopia of human polyomaviruses | |
Touzé et al. | Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies | |
Stolt et al. | Seroepidemiology of the human polyomaviruses | |
Tolstov et al. | Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays | |
Moens et al. | Serological cross‐reactivity between human polyomaviruses | |
Pastrana et al. | NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16 | |
Roden et al. | Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor | |
Belliot et al. | Characterization of capsid genes, expressed in the baculovirus system, of three new genetically distinct strains of “Norwalk-like viruses” | |
Pau et al. | Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein | |
Lindner et al. | Humoral immune response against human bocavirus VP2 virus-like particles | |
Jafar et al. | Serological evidence of SV40 infections in HIV‐infected and HIV‐negative adults | |
Lindner et al. | Human bocavirus–a novel parvovirus to infect humans | |
Malm et al. | Norovirus-specific memory T cell responses in adult human donors | |
Tamura et al. | Interaction of recombinant Norwalk virus particles with the 105-kilodalton cellular binding protein, a candidate receptor molecule for virus attachment | |
Lundstig et al. | Serological diagnosis of human polyomavirus infection | |
van Poelgeest et al. | Distinct regulation and impact of type 1 T‐cell immunity against HPV16 L1, E2 and E6 antigens during HPV16‐induced cervical infection and neoplasia | |
Hale et al. | Expression and antigenic characterization of the major capsid proteins of human polyomaviruses BK and JC in Saccharomyces cerevisiae | |
Geissler et al. | Mapping neutralizing and non‐neutralizing epitopes on the capsid protein of feline calicivirus | |
Zhang et al. | Decreased antigenicity profiles of immune-escaped and drug-resistant hepatitis B surface antigen (HBsAg) double mutants | |
Shah et al. | Simian virus 40 (SV40) and human cancer: a review of the serological data | |
Qiu et al. | Expression and characterization of virus-like particles containing rubella virus structural proteins |